In 1995, it was reported that GPIIb (CD41) mRNA was detected in patients with refractory anemia with excess blasts (RAEB) or RAEB in transformation (RAEB-t) but not in low-grade patients with MDS [10]. Here, ITGA2B is linked to myelodysplastic syndrome with excess blasts.